Commonwealth Equity Services’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-10,850
Closed -$13K 3824
2021
Q4
$13K Hold
10,850
﹤0.01% 3623
2021
Q3
$23K Buy
+10,850
New +$29.6K ﹤0.01% 3543
2019
Q2
Sell
-13,850
Closed -$148K 2831
2019
Q1
$148K Hold
13,850
﹤0.01% 2535
2018
Q4
$121K Buy
13,850
+300
+2% +$3.82K ﹤0.01% 2457
2018
Q3
$227K Sell
13,550
-100
-0.7% -$2.16K ﹤0.01% 2403
2018
Q2
$286K Buy
13,650
+2,200
+19% +$40.8K ﹤0.01% 2163
2018
Q1
$184K Buy
+11,450
New +$227K ﹤0.01% 2430
2016
Q4
Sell
-10,815
Closed -$51K 2383
2016
Q3
$51K Buy
+10,815
New +$64.1K ﹤0.01% 2165

Other funds holding SPPI

Commonwealth Equity Services's SPPI Position: Q1 2022 in Review

Commonwealth Equity Services sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 10,850 shares — an estimated $13K sold.

Commonwealth Equity Services first reported a position in SPPI in Q3 2016 and held it in 8 quarters. The position peaked at $286K in Q2 2018. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Commonwealth Equity Services reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 10,850 Spectrum Pharmaceuticals Inc shares in Q1 2022, an estimated $13K.
  • Commonwealth Equity Services first reported a position in Spectrum Pharmaceuticals Inc in Q3 2016 and held it in 8 quarters.
  • Commonwealth Equity Services's Spectrum Pharmaceuticals Inc position peaked at $286K in Q2 2018.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Commonwealth Equity Services's 13F filing for Q1 2022, filed 4 May 2022.